Omnipass Inc. – Trademark Portfolio

Entity Type: 03

Omnipass Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GHOST. The owner is based in Las Vegas, NV.

3305 Spring Mountain Road, Suite 69

Las Vegas, NV 89012

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GHOST
GHOST
Registered 2019

Trademark Classifications

Omnipass Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

38
Telecommunications (2 filings)

Telecommunications

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Omnipass Inc. have?

Omnipass Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Omnipass Inc. file in?

Omnipass Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Omnipass Inc.'s most well-known trademarks?

Omnipass Inc.'s registered trademark portfolio includes well-known marks such as GHOST. These are among 1 currently registered trademark in the portfolio.

What is Omnipass Inc.'s trademark registration success rate?

Omnipass Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.